USANA changed its loan terms, adding a minimum profit test but allowing its Australian unit to sell its Sydney property and use the money as it sees fit. The added limit and added flexibility point in different directions, and the filing reports no default, so it does not clearly change the company's outlook.
The required profit floor could restrict the company if results fall short. It drops to $70 million when lender exposure is $50 million or less. USANA also gained room to sell property, and the filing says no default exists. Those terms pull in different directions, so the filing alone does not change the outlook.
Follow USANA Health Sciences, Inc. (USNA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for USNA